3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Head & Neck
1
Conditions
Virus Diseases
1
Tumor Virus Infections
1
Squamous Cell Carcinoma of Head and Neck
1
Pharyngeal Diseases
1
Papillomavirus Infections
1
Otorhinolaryngologic Neoplasms
1
Otorhinolaryngologic Diseases
1
Oropharyngeal Neoplasms
1
Neoplasms, Squamous Cell
1
Neoplasms, Glandular and Epithelial
1
Neoplasms by Site
1
Neoplasms by Histologic Type
1
Head and Neck Neoplasms
1
DNA Virus Infections
1
Carcinoma, Squamous Cell
1
Carcinoma
1
Interventions
pembrolizumab
22
Cisplatin
17
Surveys and Questionnaires
9
Radiotherapy
8
Carboplatin
8
Radiotherapy, Intensity-Modulated
7
Cetuximab
7
Paclitaxel
6
Nivolumab
6
Drug Therapy
6
Radiation
4
Fluorouracil
4
Taxes
3
Docetaxel
3
selpercatinib
2
dostarlimab
2
Yoga
2
Surgical Procedures, Operative
2
Standard of Care
2
Radiosurgery
2
Magnetic Resonance Spectroscopy
2
Ipilimumab
2
Chemoradiotherapy
2
Blood Specimen Collection
2
ALX148
2
veliparib
1
tisotumab vedotin
1
tislelizumab
1
palbociclib
1
osimertinib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Active not recruiting
×
Head and Neck Neoplasms
×
Nimorazole
×
Clear all
NCT04124198
2025-12-31
QoLATI
Rigshospitalet, Denmark
Phase NA
Active not recruiting
138 enrolled